HLA-DR Antikörper (PerCP)
Kurzübersicht für HLA-DR Antikörper (PerCP) (ABIN2704373)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
- 
    - 
                                            Verwendungszweck
- Anti-HLA-DR PerCP Antibody
- 
                                            Produktmerkmale
- The L243 reacts with human HLA-DR antigen which is expressed on B lymphocytes, monocytes, macrophages, activated T lymphocytes, activated natural killer (NK) lymphocytes, and human progenitor cells. HLA-DR is also present on thymic epithelium, B lymphocyte dependent areas of spleen and lymph node, and B cell lymphomas.
- 
                                            Aufreinigung
- Purified
- 
                                            Reinheit
- >95 %
- 
                                            Immunogen
- Human B lymphocytes
- 
                                            Isotyp
- IgG2a, kappa
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Konzentration
- 50 μg/mL
- 
                                            Buffer
- PBS pH 7.2, 0.2 % (w/v) BSA, 0.09 % (w/v) sodium azide
- 
                                            Konservierungsmittel
- Sodium azide
- 
                                            Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- 4 °C
- 
                                            Informationen zur Lagerung
- 2-8°C, Conjugated antibodies should never be frozen.
 
- 
                                            
- 
    - HLA-DR
- 
                                            Andere Bezeichnung
- HLA-DR
- 
                                            Gen-ID
- 3122, 3123
- 
                                            NCBI Accession
- NM_019111
- 
                                            UniProt
- P01903
- 
                                            Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
 Target
- 
                    
 
                                     
                                     
                                    